Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mast cells as effector cells: a co-stimulating question.

Ido Bachelet1, Francesca Levi-Schaffer

  • 1Department of Pharmacology & Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 91120, Israel.

Trends in Immunology
|July 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melittin in AllergoOncology: From Honey Bee Venom to Anti-Cancer Therapeutic Innovation-An EAACI Position Paper.

Allergy·2026
Same author

Meaningful outcomes in food allergy immunotherapy: Measuring what counts.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Mast Cells in Acute COVID-19 Patients.

Allergy·2026
Same author

CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.

International archives of allergy and immunology·2026
Same author

New advances in our understanding of itch.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Epithelial-Immune Cell Crosstalk in Salivary Gland Tumors: Implications for Tumor Progression and Diagnostic Assessment.

International journal of molecular sciences·2025

Mast cells are key immune cells involved in allergies and other diseases. New research shows co-stimulatory molecules on mast cells offer potential therapeutic targets for various conditions.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathology

Background:

  • Mast cells are recognized as crucial effector cells beyond allergic reactions, implicated in innate immunity, autoimmunity, chronic inflammation, and atherosclerosis.
  • Previous research primarily focused on single signaling axes, like the high-affinity IgE receptor (FcεRI), for mast cell response magnitude.
  • The T cell receptor, in contrast, is understood as a complex network of stimulatory and co-stimulatory molecules regulating responses.

Purpose of the Study:

  • To explore the role of co-stimulatory molecules in mast cell function.
  • To investigate the potential contribution of these molecules to mast cell-associated pathologies.
  • To identify novel therapeutic targets for diseases involving mast cells.

Main Methods:

Related Experiment Videos

  • Review of recent observations on mast cell signaling pathways.
  • Analysis of the expression and function of co-stimulatory molecules on mast cells.
  • Evaluation of the implications of these findings for mast cell-associated diseases.

    • Main Results:

    • Mast cells express various classes of co-stimulatory molecules.
    • These co-stimulatory molecules modulate mast cell function.
    • The identified molecules may influence the outcome of mast cell-associated pathologies.

    Conclusions:

    • Co-stimulatory molecules represent a significant, yet under-explored, aspect of mast cell regulation.
    • Targeting these co-stimulatory pathways offers a promising new therapeutic strategy for mast cell-mediated diseases.
    • Further research into mast cell co-stimulation is warranted for advancing treatment options.